Phenotypic characterization of cisplatin-resistant HNSCC cell lines demonstrated an upregulation of both TrkB and its ligand, brain derived neurotrophic factor (BDNF) with a concomitant increase in cell proliferation and apoptosis. This evidence concerns the gene NTRK2 and head and neck squamous cell carcinoma.